Early Onset Pancreatic Adenocarcinoma (EOPAC): presentation, clinical course and treatment outcomes in comparison to Average Onset Pancreatic Adenocarcinoma (AOPAC): a retrospective cohort study
Patients with EOPAC in Egypt represent around 25% of cases. EOPAC tend to have a shorter disease free survival (DFS) in patients presenting with localized disease. The overall survival (OS) is longer in EOPAC compared to AOPAC. Further studies are mandatory to identify the epidemiological and risk factors of EOPAC in Egypt.
Authors
- Ismail Mohamed (ORCID: https://orcid.org/0000-0002-0163-019X)
- Samir Saheb (ORCID: https://orcid.org/0000-0002-7764-6016)
- Noha Rashad (ORCID: https://orcid.org/0000-0002-3684-9271)
- Ayman A. Gouda (ORCID: https://orcid.org/0000-0001-5967-4585)
- Esraa Sabra
- Hossam Alshazly
Institutions
- Suez University (EG)
- Al Noor Hospitals (AE)
- The University of Texas Medical Branch at Galveston (US)
- Aswan University (EG)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1186/s12885-024-12955-7
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Science and Technology Development Fund
- Suez University